Literature DB >> 18377815

Schistosomiasis in travelers and immigrants.

Edsel Maurice T Salvana1, Charles H King.   

Abstract

Schistosomiasis is caused by trematode parasites of one of five species, Schistosoma mansoni, Schistosoma haematobium, Schistosoma japonicum, Schistosoma intercalatum, or Schistosoma mekongi, acquired via skin contact with fresh water containing infectious larval cercariae. Between 1 and 8 weeks after exposure, acute schistosomiasis presents as dermatitis, fever, fatigue, or eosinophilia. If untreated, long-term infection may cause anemia or undernutrition and may progress to liver fibrosis, portal hypertension, or hydronephrosis. Schistosomiasis represents a threat to residents and visitors in all endemic areas of Africa, Asia, and South America. Travelers should be made aware of infection risk if they become exposed to untreated fresh water. New immigrants and those returning to high-risk areas to visit friends and family should be screened for signs and symptoms of acute and chronic schistosomiasis. Physicians caring for travelers and immigrants must be familiar with the signs and symptoms of schistosomiasis and must be able to diagnose and treat it correctly.

Entities:  

Year:  2008        PMID: 18377815     DOI: 10.1007/s11908-008-0009-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  36 in total

Review 1.  Schistosomiasis.

Authors:  Allen G P Ross; Paul B Bartley; Adrian C Sleigh; G Richard Olds; Yuesheng Li; Gail M Williams; Donald P McManus
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections.

Authors:  L van Lieshout; A M Polderman; A M Deelder
Journal:  Acta Trop       Date:  2000-10-23       Impact factor: 3.112

Review 3.  New policies for using anthelmintics in high risk groups.

Authors:  Henrietta E Allen; David W T Crompton; Nilanthi de Silva; Philip T LoVerde; G Richard Olds
Journal:  Trends Parasitol       Date:  2002-09

4.  Acute and chronic schistosomiasis.

Authors:  C H King
Journal:  Hosp Pract (Off Ed)       Date:  1991-03-15

5.  Acute schistosomiasis in U.S. travelers returning from Africa.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-03-09       Impact factor: 17.586

6.  Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology.

Authors:  Wouter F W Bierman; José C F M Wetsteyn; Tom van Gool
Journal:  J Travel Med       Date:  2005 Jan-Feb       Impact factor: 8.490

7.  Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.

Authors:  J Utzinger; E K N'Goran; A N'Dri; C Lengeler; S Xiao; M Tanner
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

8.  Female genital schistosomiasis.

Authors:  J A Crump; D R Murdoch; S T Chambers; D R Aickin; L A Hunter
Journal:  J Travel Med       Date:  2000-01       Impact factor: 8.490

9.  Acute schistosomiasis with transverse myelitis in American students returning from Kenya.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1984-08-10       Impact factor: 17.586

Review 10.  Imaging diagnosis of schistosomiasis japonica--the use in Japan and application for field study in the present endemic area.

Authors:  Hiroshi Ohmae; Orlando S Sy; Yuichi Chigusa; Gerundio P Portillo
Journal:  Parasitol Int       Date:  2003-12       Impact factor: 2.230

View more
  2 in total

Review 1.  Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines.

Authors:  Dorota Olender; Justyna Żwawiak; Lucjusz Zaprutko
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-29

Review 2.  Clinical Spectrum of Schistosomiasis: An Update.

Authors:  Cristina Carbonell; Beatriz Rodríguez-Alonso; Amparo López-Bernús; Hugo Almeida; Inmaculada Galindo-Pérez; Virginia Velasco-Tirado; Miguel Marcos; Javier Pardo-Lledías; Moncef Belhassen-García
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.